Non-homologous end joining mediated DNA repair is impaired in the NUP98-HOXD13 mouse model for myelodysplastic syndrome

Leukemia Research

Volumn 37, Issue 1, 2013, Pages 112-116

  Puthiyaveetil, Abdul Gafoor ^a,b   Reilly, Christopher M ^c   Pardee, Timothy S ^d   Caudell, David L ^a,b  

^a CENTER FOR MOLECULAR MEDICINE AND INFECTIOUS DISEASES   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^c EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^d WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Chromosomal translocation; DNA double strand break; HOXD13; Non homologous end joining; NUP98

Indexed keywords

XRCC4 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CHROMOSOME TRANSLOCATION; CLASS SWITCH RECOMBINATION; CONTROLLED STUDY; DNA END JOINING REPAIR; DNA LIGASE4 GENE; DNA PKCS GENE; DOUBLE STRANDED DNA BREAK; DOWN REGULATION; FUSION GENE; GENE; GENE EXPRESSION; GENETIC RECOMBINATION; MOUSE; MYELODYSPLASTIC SYNDROME; NONHUMAN; NUP98 HOXD13 GENE; PRIORITY JOURNAL; XRCC4 GENE;

ANIMALS; CELL CYCLE CHECKPOINTS; DNA BREAKS, DOUBLE-STRANDED; DNA END-JOINING REPAIR; GENE FUSION; HOMEODOMAIN PROTEINS; MICE; MYELODYSPLASTIC SYNDROMES; NUCLEAR PORE COMPLEX PROTEINS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 84870861854     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2012.10.012     Document Type: Article

References (31)

1. Caudell D., Aplan P.D. The role of CALM-AF10 gene fusion in acute leukemia. Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, UK 2008, 22:678-685.
2. Caudell D., Harper D.P., Novak R.L., Pierce R.M., Slape C., Wolff L., et al. Retroviral insertional mutagenesis identifies Zeb2 activation as a novel leukemogenic collaborating event in CALM-AF10 transgenic mice. Blood 2010, 115:1194-1203.
3. Gilliland D.G., Tallman M.S. Focus on acute leukemias. Cancer Cell 2002, 1:417-420.
4. Gilliland D.G. Molecular genetics of human leukemias: new insights into therapy. Semin Hematol 2002, 39:6-11.
5. Mladenov E., Iliakis G. Induction and repair of DNA double strand breaks: the increasing spectrum of non-homologous end joining pathways. Mutat Res 2011, 711:61-72.
6. Markowitz S.D., Bertagnolli M.M. Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med 2009, 361:2449-2460.
7. Sallmyr A., Fan J., Rassool F.V. Genomic instability in myeloid malignancies: increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair. Cancer Lett 2008, 270:1-9.
8. Skorski T. Genomic instability: the cause and effect of BCR/ABL tyrosine kinase. Curr Hematol Malig Rep 2007, 2:69-74.
9. Fan J., Li L., Small D., Rassool F. Cells expressing FLT3/ITD mutations exhibit elevated repair errors generated through alternative NHEJ pathways: implications for genomic instability and therapy. Blood 2010, 116:5298-5305.
10. Lieber M.R., Ma Y., Pannicke U., Schwarz K. Mechanism and regulation of human non-homologous DNA end-joining. Nat Rev Mol Cell Biol 2003, 4:712-720.
11. Kenter A.L. Class switch recombination: an emerging mechanism. Curr Top Microbiol Immunol 2005, 290:171-199.
12. Lieber M.R., Gu J., Lu H., Shimazaki N., Tsai A.G. Nonhomologous DNA end joining (NHEJ) and chromosomal translocations in humans. Subcell Biochem 2010, 50:279-296.
13. Nijnik A., Dawson S., Crockford T.L., Woodbine L., Visetnoi S., Bennett S., et al. Impaired lymphocyte development and antibody class switching and increased malignancy in a murine model of DNA ligase IV syndrome. J Clin Invest 2009, 119:1696-1705.
14. Slape C., Liu L.Y., Beachy S., Aplan P.D. Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl. Blood 2008, 112:2017-2019.
15. Puthiyaveetil A.G., Heid B., Reilly C.M., Hogenesch H., Caudell D.L. A NUP98-HOXD13 leukemic fusion gene leads to impaired class switch recombination and antibody production. Exp Hematol 2012, 40:622-633.
16. Stavnezer J., Guikema J.E., Schrader C.E. Mechanism and regulation of class switch recombination. Annu Rev Immunol 2008, 26:261-292.
17. Celeste A., Petersen S., Romanienko P.J., Fernandez-Capetillo O., Chen H.T., Sedelnikova O.A., et al. Genomic instability in mice lacking histone H2AX. Science 2002, 296:922-927.
18. Yin B., Savic V., Juntilla M.M., Bredemeyer A.L., Yang-Iott K.S., Helmink B.A., et al. Histone H2AX stabilizes broken DNA strands to suppress chromosome breaks and translocations during V(D)J recombination. J Exp Med 2009, 206:2625-2639.
19. Spagnolo L., Rivera-Calzada A., Pearl L.H., Llorca O. Three-dimensional structure of the human DNA-PKcs/Ku70/Ku80 complex assembled on DNA and its implications for DNA DSB repair. Mol Cell 2006, 22:511-519.
20. Calsou P., Delteil C., Frit P., Drouet J., Salles B. Coordinated assembly of Ku and p460 subunits of the DNA-dependent protein kinase on DNA ends is necessary for XRCC4-ligase IV recruitment. J Mol Biol 2003, 326:93-103.
21. Sallmyr A., Fan J., Datta K., Kim K.T., Grosu D., Shapiro P., et al. Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML. Blood 2008, 111:3173-3182.
22. Fernandes M.S., Reddy M.M., Gonneville J.R., DeRoo S.C., Podar K., Griffin J.D., et al. BCR-ABL promotes the frequency of mutagenic single-strand annealing DNA repair. Blood 2009, 114:1813-1819.
23. Lin C., Yang L., Rosenfeld M.G. Molecular logic underlying chromosomal translocations, random or non-random?. Adv Cancer Res 2012, 113:241-279.
24. Kasparek T.R., Humphrey T.C. DNA double-strand break repair pathways, chromosomal rearrangements and cancer. Semin Cell Dev Biol 2011, 22:886-897.
25. Vilenchik M.M., Knudson A.G. Inverse radiation dose-rate effects on somatic and germ-line mutations and DNA damage rates. Proc Natl Acad Sci U S A 2000, 97:5381-5386.
26. Vilenchik M.M., Knudson A.G. Endogenous DNA double-strand breaks: production, fidelity of repair, and induction of cancer. Proc Natl Acad Sci U S A 2003, 100:12871-12876.
27. Tseng R.C., Hsieh F.J., Shih C.M., Hsu H.S., Chen C.Y., Wang Y.C. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study. Cancer 2009, 115:2939-2948.
28. Choi C.W., Chung Y.J., Slape C., Aplan P.D. A NUP98-HOXD13 fusion gene impairs differentiation of B and T lymphocytes and leads to expansion of thymocytes with partial TCRB gene rearrangement. J Immunol 2009, 183:6227-6235.
29. Bothmer A., Robbiani D.F., Di Virgilio M., Bunting S.F., Klein I.A., Feldhahn N., et al. Regulation of DNA end joining, resection, and immunoglobulin class switch recombination by 53BP1. Mol Cell 2011, 42:319-329.
30. Shibata A., Barton O., Noon A.T., Dahm K., Deckbar D., Goodarzi A.A., et al. Role of ATM and the damage response mediator proteins 53BP1 and MDC1 in the maintenance of G(2)/M checkpoint arrest. Mol Cell Biol 2010, 30:3371-3383.
31. Sturgeon C.M., Knight Z.A., Shokat K.M., Roberge M. Effect of combined DNA repair inhibition and G2 checkpoint inhibition on cell cycle progression after DNA damage. Mol Cancer Ther 2006, 5:885-892.